Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Characterization of novel splice variants of zinc finger antiviral protein (ZAP).

Li MMH, Aguilar EG, Michailidis E, Pabon J, Park P, Wu X, de Jong YP, Schneider WM, Molina H, Rice CM, MacDonald MR.

J Virol. 2019 May 22. pii: JVI.00715-19. doi: 10.1128/JVI.00715-19. [Epub ahead of print]

PMID:
31118263
2.

Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids.

Hu H, Gehart H, Artegiani B, LÖpez-Iglesias C, Dekkers F, Basak O, van Es J, Chuva de Sousa Lopes SM, Begthel H, Korving J, van den Born M, Zou C, Quirk C, Chiriboga L, Rice CM, Ma S, Rios A, Peters PJ, de Jong YP, Clevers H.

Cell. 2018 Nov 29;175(6):1591-1606.e19. doi: 10.1016/j.cell.2018.11.013.

PMID:
30500538
3.

Hepatitis C Virus Neutralizing Antibodies: Is a Vaccine Still Possible?

de Jong YP.

Cell Host Microbe. 2018 Nov 14;24(5):620-621. doi: 10.1016/j.chom.2018.10.017.

PMID:
30439338
4.

Modeling Unique Patients in Humanized Mice: Toward a Curative Strategy for HIV.

Dorner M, de Jong YP.

Mol Ther. 2018 Feb 7;26(2):329-330. doi: 10.1016/j.ymthe.2018.01.003. No abstract available.

5.

A robust cell culture system supporting the complete life cycle of hepatitis B virus.

Michailidis E, Pabon J, Xiang K, Park P, Ramanan V, Hoffmann HH, Schneider WM, Bhatia SN, de Jong YP, Shlomai A, Rice CM.

Sci Rep. 2017 Nov 30;7(1):16616. doi: 10.1038/s41598-017-16882-5.

6.

Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice.

Andreo U, de Jong YP, Scull MA, Xiao JW, Vercauteren K, Quirk C, Mommersteeg MC, Bergaya S, Menon A, Fisher EA, Rice CM.

Cell Mol Gastroenterol Hepatol. 2017 Jul 19;4(3):405-417. doi: 10.1016/j.jcmgh.2017.07.002. eCollection 2017 Nov.

7.

In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease.

Stevens KR, Scull MA, Ramanan V, Fortin CL, Chaturvedi RR, Knouse KA, Xiao JW, Fung C, Mirabella T, Chen AX, McCue MG, Yang MT, Fleming HE, Chung K, de Jong YP, Chen CS, Rice CM, Bhatia SN.

Sci Transl Med. 2017 Jul 19;9(399). pii: eaah5505. doi: 10.1126/scitranslmed.aah5505.

8.

The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity.

Mendoza JL, Schneider WM, Hoffmann HH, Vercauteren K, Jude KM, Xiong A, Moraga I, Horton TM, Glenn JS, de Jong YP, Rice CM, Garcia KC.

Immunity. 2017 Mar 21;46(3):379-392. doi: 10.1016/j.immuni.2017.02.017.

9.

The Balance between CD8+ T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector Dose.

Kumar SRP, Hoffman BE, Terhorst C, de Jong YP, Herzog RW.

Mol Ther. 2017 Apr 5;25(4):880-891. doi: 10.1016/j.ymthe.2017.02.014. Epub 2017 Mar 9.

10.

Dynamics of antigen presentation to transgene product-specific CD4+ T cells and of Treg induction upon hepatic AAV gene transfer.

Perrin GQ, Zolotukhin I, Sherman A, Biswas M, de Jong YP, Terhorst C, Davidoff AM, Herzog RW.

Mol Ther Methods Clin Dev. 2016 Dec 7;3:16083. eCollection 2016.

11.

Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.

Zeremski M, Dimova RB, Pillardy J, de Jong YP, Jacobson IM, Talal AH.

J Infect Dis. 2016 Oct 15;214(8):1164-70. doi: 10.1093/infdis/jiw332. Epub 2016 Aug 2.

12.

Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells.

Billerbeck E, Mommersteeg MC, Shlomai A, Xiao JW, Andrus L, Bhatta A, Vercauteren K, Michailidis E, Dorner M, Krishnan A, Charlton MR, Chiriboga L, Rice CM, de Jong YP.

J Hepatol. 2016 Aug;65(2):334-43. doi: 10.1016/j.jhep.2016.04.022. Epub 2016 May 2.

13.

Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid.

Vercauteren K, Hoffman BE, Zolotukhin I, Keeler GD, Xiao JW, Basner-Tschakarjan E, High KA, Ertl HC, Rice CM, Srivastava A, de Jong YP, Herzog RW.

Mol Ther. 2016 Jun;24(6):1042-1049. doi: 10.1038/mt.2016.61. Epub 2016 Mar 29.

14.

Animal models for the study of HCV.

Vercauteren K, de Jong YP, Meuleman P.

Curr Opin Virol. 2015 Aug;13:67-74. doi: 10.1016/j.coviro.2015.04.009. Epub 2015 May 23. Review.

15.

Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice.

Scull MA, Shi C, de Jong YP, Gerold G, Ries M, von Schaewen M, Donovan BM, Labitt RN, Horwitz JA, Gaska JM, Hrebikova G, Xiao JW, Flatley B, Fung C, Chiriboga L, Walker CM, Evans DT, Rice CM, Ploss A.

Hepatology. 2015 Jul;62(1):57-67. doi: 10.1002/hep.27773. Epub 2015 Apr 15.

16.

Hepatitis C virus RNA functionally sequesters miR-122.

Luna JM, Scheel TK, Danino T, Shaw KS, Mele A, Fak JJ, Nishiuchi E, Takacs CN, Catanese MT, de Jong YP, Jacobson IM, Rice CM, Darnell RB.

Cell. 2015 Mar 12;160(6):1099-110. doi: 10.1016/j.cell.2015.02.025.

17.

HCV animal models and liver disease.

Vercauteren K, de Jong YP, Meuleman P.

J Hepatol. 2014 Nov;61(1 Suppl):S26-33. doi: 10.1016/j.jhep.2014.07.013. Epub 2014 Nov 3. Review.

18.

Broadly neutralizing antibodies abrogate established hepatitis C virus infection.

de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, Gerges S, Vega K, Labitt RN, Donovan BM, Giang E, Krishnan A, Chiriboga L, Charlton MR, Burton DR, Baltimore D, Law M, Rice CM, Ploss A.

Sci Transl Med. 2014 Sep 17;6(254):254ra129. doi: 10.1126/scitranslmed.3009512.

19.

Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.

Shlomai A, Schwartz RE, Ramanan V, Bhatta A, de Jong YP, Bhatia SN, Rice CM.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12193-8. doi: 10.1073/pnas.1412631111. Epub 2014 Aug 4.

20.

Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Shlomai A, de Jong YP, Rice CM.

Semin Cancer Biol. 2014 Jun;26:78-88. doi: 10.1016/j.semcancer.2014.01.004. Epub 2014 Jan 20. Review.

21.

Antisense therapy for hepatitis C virus infection.

de Jong YP, Jacobson IM.

J Hepatol. 2014 Jan;60(1):227-8. doi: 10.1016/j.jhep.2013.08.028. Epub 2013 Sep 11. No abstract available.

22.

Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial.

von Bartheld MB, Dekkers OM, Szlubowski A, Eberhardt R, Herth FJ, in 't Veen JC, de Jong YP, van der Heijden EH, Tournoy KG, Claussen M, van den Blink B, Shah PL, Zoumot Z, Clementsen P, Porsbjerg C, Mauad T, Bernardi FD, van Zwet EW, Rabe KF, Annema JT.

JAMA. 2013 Jun 19;309(23):2457-64. doi: 10.1001/jama.2013.5823.

PMID:
23780458
23.

Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease.

Kocks JW, van den Berg JW, Kerstjens HA, Uil SM, Vonk JM, de Jong YP, Tsiligianni IG, van der Molen T.

Int J Chron Obstruct Pulmon Dis. 2013;8:273-86. doi: 10.2147/COPD.S43992. Epub 2013 Jun 6.

24.

Emerging therapeutic targets for hepatitis C virus infection.

Jesudian AB, de Jong YP, Jacobson IM.

Clin Gastroenterol Hepatol. 2013 Jun;11(6):612-9.e1. doi: 10.1016/j.cgh.2013.04.003. Epub 2013 Apr 11. Review. Erratum in: Clin Gastroenterol Hepatol. 2013 Aug;11(8):1040.

PMID:
23583900
25.

Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice.

de Jong YP, Rice CM, Ploss A.

J Hepatol. 2011 May;54(5):848-50. doi: 10.1016/j.jhep.2010.09.034. Epub 2010 Oct 25. No abstract available.

26.

New horizons for studying human hepatotropic infections.

de Jong YP, Rice CM, Ploss A.

J Clin Invest. 2010 Mar;120(3):650-3. doi: 10.1172/JCI42338. Epub 2010 Feb 22.

27.

Use of spoligotyping and large sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in The Gambia.

de Jong BC, Antonio M, Awine T, Ogungbemi K, de Jong YP, Gagneux S, DeRiemer K, Zozio T, Rastogi N, Borgdorff M, Hill PC, Adegbola RA.

J Clin Microbiol. 2009 Apr;47(4):994-1001. doi: 10.1128/JCM.01216-08. Epub 2009 Feb 4.

28.

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM.

Nature. 2009 Feb 12;457(7231):882-6. doi: 10.1038/nature07684. Epub 2009 Jan 28.

29.

Oral or IV prednisolone in the treatment of COPD exacerbations: a randomized, controlled, double-blind study.

de Jong YP, Uil SM, Grotjohan HP, Postma DS, Kerstjens HA, van den Berg JW.

Chest. 2007 Dec;132(6):1741-7. Epub 2007 Jul 23.

PMID:
17646228
30.

In vivo generation of oligoclonal colitic CD4+ T-cell lines expressing a distinct T-cell receptor Vbeta.

Abadía-Molina AC, Mizoguchi A, Faubion WA, De Jong YP, Rietdijk ST, Comiskey M, Clarke K, Bhan AK, Terhorst C.

Gastroenterology. 2005 May;128(5):1268-77.

PMID:
15887110
31.

Induced reactivity of intestinal CD4(+) T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation.

Hokama A, Mizoguchi E, Sugimoto K, Shimomura Y, Tanaka Y, Yoshida M, Rietdijk ST, de Jong YP, Snapper SB, Terhorst C, Blumberg RS, Mizoguchi A.

Immunity. 2004 Jun;20(6):681-93.

32.

Colitis is associated with thymic destruction attenuating CD4+25+ regulatory T cells in the periphery.

Faubion WA, De Jong YP, Molina AA, Ji H, Clarke K, Wang B, Mizoguchi E, Simpson SJ, Bhan AK, Terhorst C.

Gastroenterology. 2004 Jun;126(7):1759-70.

PMID:
15188171
33.

Blocking inducible co-stimulator in the absence of CD28 impairs Th1 and CD25+ regulatory T cells in murine colitis.

de Jong YP, Rietdijk ST, Faubion WA, Abadia-Molina AC, Clarke K, Mizoguchi E, Tian J, Delaney T, Manning S, Gutierrez-Ramos JC, Bhan AK, Coyle AJ, Terhorst C.

Int Immunol. 2004 Feb;16(2):205-13.

PMID:
14734605
34.

Role of the CD5 molecule on TCR gammadelta T cell-mediated immune functions: development of germinal centers and chronic intestinal inflammation.

Mizoguchi A, Mizoguchi E, de Jong YP, Takedatsu H, Preffer FI, Terhorst C, Bhan AK.

Int Immunol. 2003 Jan;15(1):97-108.

PMID:
12502730
35.

Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice.

Mizoguchi E, Mizoguchi A, Takedatsu H, Cario E, de Jong YP, Ooi CJ, Xavier RJ, Terhorst C, Podolsky DK, Bhan AK.

Gastroenterology. 2002 Jan;122(1):134-44.

PMID:
11781288
36.

Development of chronic colitis is dependent on the cytokine MIF.

de Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, Mizoguchi E, Metz CN, Alsahli M, ten Hove T, Keates AC, Lubetsky JB, Farrell RJ, Michetti P, van Deventer SJ, Lolis E, David JR, Bhan AK, Terhorst C.

Nat Immunol. 2001 Nov;2(11):1061-6. Erratum in: Nat Immunol 2002 Apr;3(4):407. Sahli MA [corrected to Alsahli M].

PMID:
11668338
37.

Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice.

Veltkamp C, Tonkonogy SL, De Jong YP, Albright C, Grenther WB, Balish E, Terhorst C, Sartor RB.

Gastroenterology. 2001 Mar;120(4):900-13.

PMID:
11231944
38.

Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration.

De Jong YP, Comiskey M, Kalled SL, Mizoguchi E, Flavell RA, Bhan AK, Terhorst C.

Gastroenterology. 2000 Sep;119(3):715-23.

PMID:
10982766
39.

Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice.

Saubermann LJ, Beck P, De Jong YP, Pitman RS, Ryan MS, Kim HS, Exley M, Snapper S, Balk SP, Hagen SJ, Kanauchi O, Motoki K, Sakai T, Terhorst C, Koezuka Y, Podolsky DK, Blumberg RS.

Gastroenterology. 2000 Jul;119(1):119-28.

PMID:
10889161
40.

Pathways of T cell pathology in models of chronic intestinal inflammation.

Simpson SJ, de Jong YP, Comiskey M, Terhorst C.

Int Rev Immunol. 2000;19(1):1-37. Review. No abstract available.

PMID:
10723675
41.

High- and low-affinity single-peptide/MHC ligands have distinct effects on the development of mucosal CD8alphaalpha and CD8alphabeta T lymphocytes.

Levelt CN, de Jong YP, Mizoguchi E, O'Farrelly C, Bhan AK, Tonegawa S, Terhorst C, Simpson SJ.

Proc Natl Acad Sci U S A. 1999 May 11;96(10):5628-33.

42.

T cells in mouse models of gut inflammation.

Simpson SJ, de Jong YP, Comiskey M, Terhorst C.

Chem Immunol. 1998;71:118-38. Review. No abstract available.

PMID:
9761951
43.

Consequences of Fas-ligand and perforin expression by colon T cells in a mouse model of inflammatory bowel disease.

Simpson SJ, De Jong YP, Shah SA, Comiskey M, Wang B, Spielman JA, Podack ER, Mizoguchi E, Bhan AK, Terhorst C.

Gastroenterology. 1998 Oct;115(4):849-55.

PMID:
9753487
44.

Development of colonic adenocarcinomas in a mouse model of ulcerative colitis.

Shah SA, Simpson SJ, Brown LF, Comiskey M, de Jong YP, Allen D, Terhorst C.

Inflamm Bowel Dis. 1998 Aug;4(3):196-202.

PMID:
9741021
46.

Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes.

de Winter RJ, Manten A, de Jong YP, Adams R, van Deventer SJ, Lie KI.

Heart. 1997 Dec;78(6):598-602.

Supplemental Content

Loading ...
Support Center